Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Emma

Showing results (121-130 of 225) with videos related to

Pageof 23
Sort By:
Pediatric Nephrology (Berlin, Germany)|March 24, 2025
Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patientsMartina Riganati, Ester Conversano, Federica Zotta, et al.
Pediatric Nephrology (Berlin, Germany)|July 16, 2025
Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosisIsabella Guzzo, Marco Becilli, Andrea Cappoli, et al.
Kidney International|May 17, 2016
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceCraig B Langman, Bruce A Barshop, Georges Deschênes, et al.
European Journal of Pediatrics|November 14, 2024
Cystinosis metabolic bone disease: inflammatory profile in human peripheral blood mononuclear cells and derived osteoclastsCandide Alioli, Marcella Greco, Marie-Noëlle Méaux, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 3, 2024
Long-term effects of luteolin in a mouse model of nephropathic cystinosisEster De Leo, Anna Taranta, Roberto Raso, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2026
Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised studyAgnès Linglart, Francesco Emma, Justine Bacchetta, et al.
Frontiers in Immunology|April 18, 2024
<i>Nlrp2</i> deletion ameliorates kidney damage in a mouse model of cystinosisMarianna Nicoletta Rossi, Valentina Matteo, Francesca Diomedi-Camassei, et al.
Frontiers in Immunology|August 6, 2019
Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic SyndromeManuela Colucci, Rita Carsetti, Jessica Serafinelli, et al.
Kidney International|February 8, 2025
Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategyFelicitas E Hengel, Silke Dehde, Alev Yilmaz, et al.
Stem Cells and Development|July 19, 2014
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cellsMaria Manuela Rosado, Maria Ester Bernardo, Marco Scarsella, et al.
Pageof 23

Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
Pediatric Nephrology (Berlin, Germany)|March 24, 2025
Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patientsMartina Riganati, Ester Conversano, Federica Zotta, et al.
Pediatric Nephrology (Berlin, Germany)|July 16, 2025
Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosisIsabella Guzzo, Marco Becilli, Andrea Cappoli, et al.
Kidney International|May 17, 2016
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceCraig B Langman, Bruce A Barshop, Georges Deschênes, et al.
European Journal of Pediatrics|November 14, 2024
Cystinosis metabolic bone disease: inflammatory profile in human peripheral blood mononuclear cells and derived osteoclastsCandide Alioli, Marcella Greco, Marie-Noëlle Méaux, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 3, 2024
Long-term effects of luteolin in a mouse model of nephropathic cystinosisEster De Leo, Anna Taranta, Roberto Raso, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2026
Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised studyAgnès Linglart, Francesco Emma, Justine Bacchetta, et al.
Frontiers in Immunology|April 18, 2024
<i>Nlrp2</i> deletion ameliorates kidney damage in a mouse model of cystinosisMarianna Nicoletta Rossi, Valentina Matteo, Francesca Diomedi-Camassei, et al.
Frontiers in Immunology|August 6, 2019
Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic SyndromeManuela Colucci, Rita Carsetti, Jessica Serafinelli, et al.
Kidney International|February 8, 2025
Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategyFelicitas E Hengel, Silke Dehde, Alev Yilmaz, et al.
Stem Cells and Development|July 19, 2014
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cellsMaria Manuela Rosado, Maria Ester Bernardo, Marco Scarsella, et al.
Pageof 23